Shepard S L, Hadley A G
Bristol Institute for Transfusion Sciences, UK.
Immunology. 1997 Feb;90(2):314-22. doi: 10.1046/j.1365-2567.1997.00152.x.
Monocyte-binding monoclonal antibodies (mAbs) inhibited the Fc gamma receptor I (Fc gamma RI)-mediated phagocytosis of red cells sensitized with human monoclonal immunoglobulin G (IgG) anti-D (E-IgG) via three distinct mechanisms depending on their specificity. First, all monocyte-binding mAbs tested inhibited the adherence (and hence the phagocytosis) of E-IgG. They also inhibited the binding of fluorescein isothiocyanate (FITC) conjugated IgG anti-D. This inhibition of ligand binding was more efficiently promoted by murine (m) IgG2a than mIgG1 mAbs and presumably involved receptor blockade via the formation of antigen (Ag)-mAb-Fc gamma RI complexes on the monocyte membrane. Monocytes passively sensitized with human monoclonal anti-D (M-IgG) were used in experiments to distinguish between inhibition of ligand binding and inhibition of phagocytosis. In this way, it was shown that mAbs to transmembrane molecules (CD11b/CD18, CD44, and HLA) inhibited the phagocytosis of red cells adherent to M-IgG. Under the same conditions, mAbs to glycosylphosphatidylinositol (GPI) linked molecules (CD14, CD55 and CD59) did not inhibit phagocytosis. These data suggested a second mechanism of inhibition of Fc gamma RI-mediated phagocytosis that involved the cross-linking of a proportion of Fc gamma RI (i.e. those not ligated with IgG anti-D) to molecules which are relatively constrained in the cell membrane. A third mechanism of inhibition was revealed by the use of F(ab')2 fragments of mAb to CD11b which inhibited Fc gamma RI-mediated interactions with E-IgG in a manner that did not involve IgG (Fc) crosslinking or blockade of Fc gamma RI. In this respect, Fc gamma RI-mediated phagocytosis was more susceptible to inhibition than receptor-mediated adherence.
单核细胞结合单克隆抗体(mAb)通过三种不同机制抑制了Fcγ受体I(FcγRI)介导的对用人源单克隆免疫球蛋白G(IgG)抗-D(E-IgG)致敏的红细胞的吞噬作用,具体取决于它们的特异性。首先,所有测试的单核细胞结合mAb均抑制E-IgG的黏附(进而抑制吞噬作用)。它们还抑制异硫氰酸荧光素(FITC)偶联的IgG抗-D的结合。与mIgG1 mAb相比,鼠(m)IgG2a能更有效地促进这种配体结合的抑制,推测这涉及通过在单核细胞膜上形成抗原(Ag)-mAb-FcγRI复合物来阻断受体。用人源单克隆抗-D(M-IgG)被动致敏的单核细胞用于实验,以区分配体结合抑制和吞噬作用抑制。通过这种方式,发现针对跨膜分子(CD11b/CD18、CD44和HLA)的mAb抑制了黏附于M-IgG的红细胞的吞噬作用。在相同条件下,针对糖基磷脂酰肌醇(GPI)连接分子(CD14、CD55和CD59)的mAb不抑制吞噬作用。这些数据提示了抑制FcγRI介导的吞噬作用的第二种机制,即一部分FcγRI(即那些未与IgG抗-D结合的FcγRI)与细胞膜中相对受限的分子交联。通过使用抗CD11b mAb的F(ab')2片段揭示了第三种抑制机制,该片段以不涉及IgG(Fc)交联或FcγRI阻断的方式抑制FcγRI介导的与E-IgG的相互作用。在这方面,FcγRI介导的吞噬作用比受体介导的黏附更易受到抑制。